20
Participants
Start Date
November 16, 2015
Primary Completion Date
May 13, 2016
Study Completion Date
May 13, 2016
PF-06669571
1 milligram (mg) QD for 3 days followed by 3 mg QD for 4 days
Placebo
Placebo
Atlanta Center for Medical Research, Atlanta
MD Clinical, Hallandale
QPS-MRA, LLC (Broward Research Group), Hollywood
Qps-Mra Llc, South Miami
QPS-MRA, LLC (Miami research Associates), South Miami
QPS-MRA, LLC (MRA Clinical Research), South Miami
CTI Clinical Research Center, Cincinnati
Pfizer New Haven Clinical Research Unit, New Haven
CRI Worldwide, LLC, Marlton
Lead Sponsor
Pfizer
INDUSTRY